Interestingly, FAM134B acts as an oncogene in hepatocellular carcinoma (HCC) and esophageal squamous cell carcinoma (ESCC), while it acts as a tumor suppressor in colorectal cancer (CRC) and breast cancer [34]. This evidence concerns the gene RETREG1 and colorectal cancer.